Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The results demonstrated that semaglutide met the standard for non-inferiority to placebo for cardiovascular safety
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3)
Obesity Science & Practice, [online] 3(1), pp.314
Changes that can affect you this year: In the below cases, you will be affected by coverage changes during the year: New generic drugs We may immediately remove a brand-name drug on our drug list if we are replacing it with a new generic drug that will appear on the same or lower cost-sharing tier and with the same or fewer restrictions
Digestive upset
US$ 23.98
US$ 28.72
US$ 22.59
US$ 25.04
US$ 28.01
